Envision Healthcare's earnings have declined in recent years, which Zacks analysts attribute to the company's rising operating expenses.
Here are six things to know:
1. The company's operating expenses increased 191.4 percent, higher than revenue growth of 165 percent.
2. This discrepancy will put mounting pressuring on Envision's financial standing, Zack analysts project.
3. Zacks analysts are "concerned" about Envision's 2017 guidance. Previously, the company issued revenue guidance of $7.08 billion to $8.05 billion. Recent guidance places these figures between $7.75 billion and $8 billion.
4. Compared to this time last year, shares have declined 16.7 percent.
5. Envision's total debt was $5.79 million as of Dec. 31, 2016.
6. Zacks has a "sell" rating on the company's shares.